These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 9557522)

  • 1. An intradermal vaccine protocol against hepatitis B in a haemodialysis population.
    Vincent L; John GT; Abraham P; Jacob CK
    Natl Med J India; 1998; 11(1):48. PubMed ID: 9557522
    [No Abstract]   [Full Text] [Related]  

  • 2. Intramuscular or intradermal hepatitis B vaccine administration in hemodialysis patients?
    Medeiros RH; Figueiredo AE; Poli de Figueiredo CE; d'Avila D; de Los Santos CA
    Am J Kidney Dis; 2009 Nov; 54(5):981-2; author reply 982. PubMed ID: 19853202
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomised controlled trial of intradermal hepatitis B vaccination and augmentation of response with erythropoietin.
    Anandh U; Thomas PP; Shastry JC; Jacob CK
    J Assoc Physicians India; 2000 Nov; 48(11):1061-3. PubMed ID: 11310381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of low dose intradermal recombinant hepatitis B vaccine with and without immunomodulation in end stage renal disease patients on maintenance hemodialysis.
    Sirsat RA; Shah BV; Nair S; Shetty D; Rodriguest C; Mehta A
    J Assoc Physicians India; 1995 Mar; 43(3):191-2. PubMed ID: 11256907
    [No Abstract]   [Full Text] [Related]  

  • 6. Meta-analysis: intradermal vs. intramuscular vaccination against hepatitis B virus in patients with chronic kidney disease.
    Fabrizi F; Dixit V; Magnini M; Elli A; Martin P
    Aliment Pharmacol Ther; 2006 Aug; 24(3):497-506. PubMed ID: 16886915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis B vaccine administered by intradermal route in patients with celiac disease unresponsive to the intramuscular vaccination schedule: a pilot study.
    Leonardi S; Del Giudice MM; Spicuzza L; Spina M; La Rosa M
    Am J Gastroenterol; 2010 Sep; 105(9):2117-9. PubMed ID: 20818367
    [No Abstract]   [Full Text] [Related]  

  • 8. [Intradermal hepatitis B vaccination in workers not responsive to intramuscular vaccination].
    Bauer H; Potasman I; Pick N
    Harefuah; 1998 Mar; 134(6):441-4, 503. PubMed ID: 10909572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-dose intradermal and subcutaneous versus intramuscular hepatitis B vaccination in primary non-responding hemodialysis patients.
    Sorkhi H; Dooki MR; Ebrahimnejad MS
    J Med Assoc Thai; 2006 Oct; 89(10):1648-53. PubMed ID: 17128839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination against hepatitis B in patients on chronic haemodialysis.
    Kovacic V
    Int J Clin Pract; 2003 Apr; 57(3):161-2. PubMed ID: 12723714
    [No Abstract]   [Full Text] [Related]  

  • 11. The evaluation of the effectiveness of multiple dose intradermal hepatitis B re-vaccination in hemodialyzed patients not responding to standard method of immunization.
    Radziszewski A; Gajda M; Pituch-Noworolska A; Drozdz M; Kraśniak A; Kaczmarczyk I; Hołyś S; Zurowski J; Sydor A; Sułowicz W
    Przegl Lek; 2007; 64(7-8):470-5. PubMed ID: 18409347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low dose intradermal vaccination is superior to high dose intramuscular vaccination for hepatitis B in unresponsive hemodialysis patients.
    Micozkadioglu H; Zumrutdal A; Torun D; Sezer S; Ozdemir FN; Haberal M
    Ren Fail; 2007; 29(3):285-8. PubMed ID: 17497441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intradermal hepatitis B vaccination in patients with advanced chronic renal failure: immunogenicity and follow-up.
    Morais EO; Resende MR; Oliveira AM; Sinkoc VM; Garcia MT; Angerami RN; da Silva LJ
    Aliment Pharmacol Ther; 2007 Apr; 25(7):849-55. PubMed ID: 17373924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative immunogenicity of 2 recombinant hepatitis B vaccines (GeneVac-B and Engerix-B) in adult patients with chronic renal failure.
    Rajapurkar MM; Gang S; Dabhi M; Kulkarni PS
    J Nephrol; 2007; 20(5):596-601. PubMed ID: 17918146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of intramuscular and intradermal applications of hepatitis B vaccine in hemodialysis patients.
    Karahocagil MK; Buzgan T; Irmak H; Karsen H; Akdeniz H; Akman N
    Ren Fail; 2006; 28(7):561-5. PubMed ID: 17035164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of anti-HBV vaccine efficacy given intradermally and intramuscularly in hemodialysis patients].
    Miłkowski A; Wyrwicz G; Kubit P; Smoleński O
    Przegl Lek; 2000; 57(11):628-34. PubMed ID: 11293210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Rapid vaccination protocol against hepatitis B in patients with chronic kidney failure].
    Teruel JL; Fernández Lucas M; Mateos ML; Ortuño J
    Nefrologia; 2005; 25(3):338-9. PubMed ID: 16053018
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy of intradermal hepatitis B vaccination compared to intramuscular vaccination in hemodialysis patients.
    Chanchairujira T; Chantaphakul N; Thanwandee T; Ong-Ajyooth L
    J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S33-40. PubMed ID: 17044452
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc supplementation and hepatitis B vaccination in chronic haemodialysis patients: a multicentre study.
    Brodersen HP; Holtkamp W; Larbig D; Beckers B; Thiery J; Lautenschläger J; Probst HJ; Ropertz S; Yavari A
    Nephrol Dial Transplant; 1995; 10(9):1780. PubMed ID: 8559509
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatitis B vaccination in patients on chronic hemodialysis].
    Kovacić V; Sain M; Vukman V
    Lijec Vjesn; 2003; 125(5-6):156-8. PubMed ID: 14533468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.